Estrogen_and_progesterone_receptors_in_lymphangioleiomyomatosis,_epithelioid_hemangioendothelioma,_and_sclerosing_hemangioma_of_the_lung._The_therapeutic_options_in_the_treatment_of_lung_neoplasia_usually_have_not_included_hormonal_therapy,_unlike_those_for_primary_tumors_of_other_sites_(e.g.,_breast)._However,_two_mesenchymal_proliferations_of_lung,_lymphangioleiomyomatosis_and_epithelioid_hemangioendothelioma_(EHE),_and_one_epithelial_tumor,_sclerosing_hemangioma_(SH),_have_a_significant_female_predilection_and_may_benefit_from_such_hormonal_therapy._The_authors_investigated_five_cases_each_of_EHE_and_lymphangioleiomyomatosis_and_four_cases_of_SH_for_expression_of_estrogen_and_progesterone_receptors_and_17-beta_estradiol_in_paraffin-embedded_tissue._Only_one_case_each_of_lymphangioleiomyomatosis_and_EHE_expressed_17-beta_estradiol._All_of_the_other_cases_were_negative._These_findings_are_contrary_to_the_viewpoint_held_in_published_literature,_especially_in_case_reports_of_lymphangioleiomyomatosis,_describing_patients_with_positive_estrogen_and_progesterone_receptor_results._Consequently,_a_number_of_issues_must_be_considered_in_the_clinical_and_immunohistochemical_evaluation_of_the_estrogen_and_progesterone_receptor_status_of_these_rare_pulmonary_neoplasms.